SiBone (NASDAQ:SIBN) Insider Sells $84,105.00 in Stock

SiBone (NASDAQ:SIBN) insider Anshul Maheshwari sold 3,738 shares of the stock in a transaction dated Thursday, October 29th. The shares were sold at an average price of $22.50, for a total transaction of $84,105.00. Following the completion of the sale, the insider owned 214,497 shares of the company’s stock, valued at approximately $4,826,182.50. The trade was a 1.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Anshul Maheshwari also recently made the following trade(s):

• On Monday, October 5th, Anshul Maheshwari sold 1,731 shares of SiBone stock. The stock was sold at an average price of $19.50, for a total value of $33,754.50.
• On Friday, October 2nd, Anshul Maheshwari sold 3,318 shares of SiBone stock. The shares were sold at an average price of $18.18, for a total value of $60,321.24.
• On Monday, August 24th, Anshul Maheshwari sold 11,636 shares of SiBone stock. The shares were sold at an average price of $20.11, for a total value of $233,999.96.
• On Friday, August 21st, Anshul Maheshwari sold 11,228 shares of SiBone stock. The shares were sold at an average price of $20.02, for a total value of $224,784.56.
• On Wednesday, August 19th, Anshul Maheshwari sold 5,747 shares of SiBone stock. The shares were sold at an average price of $19.55, for a total value of $112,353.85.
• On Monday, August 17th, Anshul Maheshwari sold 4,665 shares of SiBone stock. The stock was sold at an average price of $18.65, for a total value of $87,002.25.

SiBone Stock Performance

Shares of SIBN stock traded down $1.01 during mid-day trading on Monday, reaching $20.22. The stock had a trading volume of 1,371,299 shares, compared to its average volume of 616,959. SiBone has a one year low of $11.48 and a one year high of $22.95. The firm has a market cap of $896.74 million, a PE ratio of -59.47 and a beta of 0.66. The firm’s 50 day simple moving average is $19.41 and its 200 day simple moving average is $16.44. The company has a quick ratio of 7.55, a current ratio of 9.15 and a debt-to-equity ratio of 0.20.

SiBone (NASDAQ:SIBN) last released its quarterly earnings data on Monday, November 2nd. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.05. The business had revenue of $55.70 million for the quarter, compared to analysts’ expectations of $55.31 million. SiBone had a negative return on equity of 8.23% and a negative net margin of 6.85%. On average, analysts forecast that SiBone will post -0.40 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Weiss Ratings upgraded shares of SiBone from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 20th. TD Cowen increased their price objective on shares of SiBone from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. UBS Group raised their price objective on shares of SiBone from $24.00 to $25.00 and gave the stock a “buy” rating in a report on Tuesday, August 4th. Finally, Truist Financial raised their price objective on shares of SiBone from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Wednesday, October 14th. Six analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, SiBone presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.50.

Institutional Investors Weigh In On SiBone

Large investors have recently modified their holdings of the stock. First Light Asset Management LLC raised its holdings in shares of SiBone by 51.8% in the 2nd quarter. First Light Asset Management LLC now owns 8,127,985 shares of the company’s stock worth $132,649,000 after buying an additional 2,774,795 shares in the last quarter. Granahan Investment Management LLC lifted its position in shares of SiBone by 97.6% during the 1st quarter. Granahan Investment Management LLC now owns 1,739,097 shares of the company’s stock worth $21,965,000 after buying an additional 858,942 shares during the period. Paradigm Capital Management Inc. NY lifted its position in shares of SiBone by 113.3% during the 1st quarter. Paradigm Capital Management Inc. NY now owns 1,126,500 shares of the company’s stock worth $14,228,000 after buying an additional 598,300 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of SiBone by 41.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 618,939 shares of the company’s stock worth $7,816,000 after buying an additional 182,465 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in SiBone by 101.6% in the 1st quarter. Renaissance Technologies LLC now owns 472,619 shares of the company’s stock valued at $5,969,000 after buying an additional 238,219 shares in the last quarter. 98.11% of the stock is currently owned by institutional investors.

About SiBone

SI-BONE, Inc (NASDAQ: SIBN) is a medical device company focused on diagnosing and treating disorders of the sacroiliac joint, which connects the spine to the pelvis. The company develops minimally invasive surgical solutions intended to stabilize the sacroiliac joint and address sacroiliac joint dysfunction and related conditions.

Its product portfolio is centered on the iFuse Implant System, a family of triangular implants designed to be placed across the sacroiliac joint. SI-BONE also offers products such as iFuse-TORQ, a threaded implant system, and iFuse Bedrock Granite, which is designed for sacroiliac joint fusion and pelvic fixation as part of certain spinal procedures.